Software Updates Simplify Protein Analysis For Avacta’s Optim® Instruments
Avacta Analytical has released a number of software updates for its innovative Optim® series of biophysical characterization instruments. Designed to reduce the time and cost of therapeutic protein preformulation studies, the compact and robust Optim instruments can probe multiple protein stability¬ indicating parameters at high speed using ultra-low sample volumes. The latest software updates have been developed to streamline this process, offering faster, more flexible operation and analysis.
Optim Client v2.1 instrument control software offers a number of exciting new features to simplify and accelerate research workflows, increasing measurement flexibility and allowing users to define custom experimental parameters. This dramatically increases the dynamic range of the instrument, enabling laboratories to adapt their assay parameters to new labels or changing experimental requirements with a built-in method designer and freeform thermal profiling options. Optim Client v2.1 also offers a number of additional pre-programmed settings for common applications – including determination of extinction coefficients, thermal refolding and relative viscosity – as well as a host of other improvements designed to simplify routine operation.
These updates are complemented by the new Optim Analysis v2.1 software, which has been entirely re¬written for greater speed, flexibility and user-friendliness. The software offers a number of enhanced methods – including revised melting point analysis to improve the quality and robustness of data – as well as new analytical tools and on-the-fly data processing, to help researchers get the most out of each measurement.
For more information, visit www.avactaanalytical.com/optim-2
About Avacta Analytical
Headquartered in Wetherby, UK, with a network of distributors, partners and applications laboratories in all the major continents of the world, Avacta Analytical provides innovative instrumentation to the biopharmaceutical market. The Company’s focus is to equip customers with a broad range of capabilities, enabling them to develop their therapeutics quicker, cheaper and better.
Avacta’s groundbreaking Optim 1000 instrument combined the powerful analytical capabilities of fluorescence and static light scattering technologies to probe multiple stability-indicating parameters at high speed, using ultra-low sample volumes of proteins and other molecules. Building on this success, the Optim 2, launched in 2013, offers even faster analysis and a wider range of measurement capabilities, complemented by enhanced acquisition and analysis software. The Optim technology provides greater insight at lower cost, and has now been adopted by most of the top global biopharmaceutical companies. This, together with a growing list of academic partners and citations, confirms Avacta’s position as a creator of original, high quality instruments
Avacta Analytical is an ISO 9001 2008 registered company.
Help employers find you! Check out all the jobs and post your resume.